Novartis: A Cohesive Platform for Clinical Trial DHT Regulatory Acceptance
In a highly anticipated session at Panagora Pharma’s 7th Digital Biomarkers in Clinical Trials Summit, Mireille Muller, Executive Director...
Search results for:
DHT
EMA Needs To Release DHT Guidance Now
As digital health technologies (DHTs) increasingly permeate the landscape of clinical trials, the European Medicines Agency (EMA) faces mounting...
How To Engage The FDA when Building Clinical Trial DHTs
Integrating Digital Health Technologies (DHTs) in drug development is revolutionizing clinical trials, especially with the rise of decentralized clinical...
Abbvie Leads The Way With DHTs in Clinical Trials
At the 2024 SCOPE Summit, AbbVie’s Digital Science Head, Michelle Crouthamel, presented compelling case studies on Aleve PM and...
Your New Guide to Validate Clinical Trial DHTs
The advent of sensor-based Digital Health Technologies (sDHTs) is transforming the landscape of clinical research and patient care. I...
How Technology Can Address Upcoming Big Pharma Financial Crunch
In this interview, we speak with Jim Corrigan, CEO of YPrime, about the future of clinical trial technologies. The...
AI and ML in Drug Development – A Deep Dive at DPHARM
The DPHARM conference brought together a panel of experts to discuss the transformative potential of Artificial Intelligence (AI) and...
Unpacking FDA Guidance on Digital Health Technologies in Clinical Trials
Digital Health Technologies (DHTs) use in clinical research is no longer a futuristic concept—it’s quickly becoming the norm. Recognizing...
Is Big Pharma in Decline?
This is an AI-Generated podcast. The pharmaceutical industry, often viewed as a pillar of global innovation, is facing a...
Is Big Pharma in Decline? Layoffs, Financial Strain, and the Future of Clinical Trials
Traditionally regarded as a cornerstone of global innovation, the pharmaceutical industry now faces unprecedented challenges, prompting even the largest...